What the network provides:
01
Community Insight Generation
The CF AMR Syndicate Network is unique in the breadth and diversity of its cross-sector community. By working closely with academics, industry experts, clinicians, patient organisations, and people with cystic fibrosis, we generate fresh insights that inform innovation and guide decision-making.
We harness the collective knowledge of this diverse network to identify opportunities, co-develop solutions, and tackle challenges in CF antimicrobial and diagnostic research. We've leveraged the network to develop our Target Product Profiles (TPPs) to ensure products are aligned with real-world needs, and we've helped catalyse collaborative grants of work, such as PIPE-CF.
The CF AMR Syndicate Network is unique in the breadth and diversity of its cross-sector community. By working closely with academics, industry experts, clinicians, patient organisations, and people with cystic fibrosis, we generate fresh insights that inform innovation and guide decision-making.
We harness the collective knowledge of this diverse network to identify opportunities, co-develop solutions, and tackle challenges in CF antimicrobial and diagnostic research. We've leveraged the network to develop our Target Product Profiles (TPPs) to ensure products are aligned with real-world needs, and we've helped catalyse collaborative grants of work, such as PIPE-CF.
02
Access to Expertise and Translational Support
Innovators can leverage the CF AMR Syndicate Network to take discoveries further than they could alone. Through the network, innovators gain access to:
By engaging with our network, innovators benefit from practical support and connections that help move ideas from concept to real-world impact.
Innovators can leverage the CF AMR Syndicate Network to take discoveries further than they could alone. Through the network, innovators gain access to:
- Expertise spanning academia, industry, clinical teams, and patient organisations
- Strategic guidance and insight to help de-risk projects and strengthen development pathways
- Collaborators who can accelerate the translation of discoveries in CF and beyond
By engaging with our network, innovators benefit from practical support and connections that help move ideas from concept to real-world impact.
03
Engagement and Participation
Join a uniquely focused collaborative community actively working to unleash solutions for CF and other chronic infections.
The CF AMR Syndicate drives innovation and translates discoveries into real-world impact. By engaging with our network, you can benefit from cross-sector insight, accelerate progress, and turn innovative ideas into tangible solutions for people living with cystic fibrosis and other chronic infections.
Join a uniquely focused collaborative community actively working to unleash solutions for CF and other chronic infections.
The CF AMR Syndicate drives innovation and translates discoveries into real-world impact. By engaging with our network, you can benefit from cross-sector insight, accelerate progress, and turn innovative ideas into tangible solutions for people living with cystic fibrosis and other chronic infections.
Become a member
Anyone working in or interested in CF infection research can sign up to join the CF AMR Syndicate Network for free.
By signing up to the network, you will:
- Receive the latest news and events in chronic infection research via the CF AMR Syndicate newsletter
- Have the opportunity to connect with potential collaborators by sharing your expertise and capabilities so that we can make relevant introductions
- Be contacted when relevant engagement, funding or collaboration opportunities arise
- Gain access to cross-sector events and symposiums
By signing up to the network, you will:
Receive the latest news and events in CF infection research via the CF AMR Syndicate newsletter.
Have the opportunity to identify new collaborators by telling us about your expertise and capabilities so that we can make relevant introductions.
Be contacted if any relevant collaboration opportunities arise.